China Secures Title As World's Largest Exporter Of Capsule Production Equipment, Holding 66% Global Share

Jan 03, 2026

Leave a message

Latest industry statistics and trade data have confirmed that China has firmly established itself as the world's largest exporter of fully automatic capsule production equipment. With a global export volume share of 66%, China's dominance in this sector is striking-data shows that in the most recent statistical cycle, Chinese capsule production equipment exports reached 587 batches, far outpacing Italy, the second-largest exporter, which recorded only 72 batches. This remarkable achievement not only reflects the rapid upgrading of China's pharmaceutical equipment manufacturing industry but also signifies a profound shift in the global supply chain pattern of capsule production equipment.

 

The 66% global export share is a milestone for China's pharmaceutical equipment sector, marking its transition from a "major manufacturer" to a "leading exporter." For decades, European countries represented by Italy have long occupied a dominant position in the global high-end pharmaceutical equipment market. However, in recent years, Chinese enterprises have accelerated technological innovation and industrial upgrading, gradually breaking the European monopoly. The huge gap in export batches-587 batches for China versus 72 batches for Italy-clearly demonstrates the strong competitiveness of Chinese capsule production equipment in terms of supply capacity, cost-effectiveness and market adaptability.

 

A number of factors have driven China's rise as the top exporter of capsule production equipment. First, continuous technological breakthroughs have laid a solid foundation. Chinese manufacturers such as Tofflon, Xinte Pharmaceutical Equipment and Shenyang Chucheng Intelligent have developed a full range of products covering hard capsule, soft capsule, plant-based capsule (HPMC) and enteric-coated capsule production lines. These equipment integrate advanced technologies such as AI visual inspection systems (with an accuracy rate of 98%), MES intelligent management and control systems, and modular flexible production designs, fully meeting the GMP compliance requirements of global pharmaceutical markets. For example, the fifth-generation intelligent hard capsule production line developed by leading enterprises can achieve a production capacity of 300,000 capsules per hour, which is comparable to international high-end products while maintaining a significant cost advantage.

 

Second, cost-effectiveness has become a core competitive edge. Compared with European equipment of similar performance, Chinese capsule production lines are priced 30%-50% lower, thanks to the complete industrial chain supporting system in China's manufacturing sector and the economies of scale formed by large-scale production. This advantage has made Chinese equipment highly popular in emerging pharmaceutical markets such as Iraq, Vietnam, Southeast Asia, Africa and Latin America. Taking Iraq as an example, local pharmaceutical enterprises have actively purchased NJP-3800D fully automatic capsule filling machines and NJY-300C liquid capsule equipment from Chinese manufacturers like Guangdong Ruijinqi, which effectively solve the pain points of local low production efficiency and poor product quality.

 

Third, the continuous expansion of export markets has further consolidated China's leading position. In addition to traditional emerging markets, Chinese capsule production equipment has also gradually entered some developed markets by virtue of improved product quality and international certification. At present, Chinese capsule equipment has obtained CE, FDA and other international certifications, enabling it to meet the technical and quality standards of European and American markets. The 587 export batches cover more than 80 countries and regions around the world, forming a global sales network that spans Asia, Africa, Latin America and Europe.

 

The data comparison with Italy is particularly illustrative of China's market dominance. Italy, once a leader in the global pharmaceutical equipment industry, has seen its market share gradually eroded due to factors such as high production costs and relatively slow technological iteration. With only 72 export batches in the same statistical period, Italy's export volume is less than one-eighth of China's. Industry analysts point out that the gap not only lies in the quantity of exports but also in the diversity of product categories and the speed of technological upgrading. Chinese manufacturers can quickly launch customized equipment according to the specific needs of different markets, while European manufacturers often have longer R&D and delivery cycles.

 

The rise of China as the world's largest exporter of capsule production equipment has had a profound impact on the global pharmaceutical industry. It has not only lowered the threshold for pharmaceutical manufacturers in emerging markets to upgrade their production equipment but also promoted the global popularization of high-quality and low-cost capsule production technology. At the same time, it has driven the export of supporting industries such as stainless steel, electrical components and intelligent control systems in China, forming a synergistic effect of industrial chain development.